Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.

[1]  Á. López-González,et al.  Dietary Intervention on Overweight and Obesity after Confinement by COVID-19 , 2023, Nutrients.

[2]  E. Dikaiakou,et al.  Hypertriglyceridemic Waist Phenotype and Its Association with Metabolic Syndrome Components, among Greek Children with Excess Body Weight , 2023, Metabolites.

[3]  M. Rizzo,et al.  The Role of Advanced Glycation End Products on Dyslipidemia , 2023, Metabolites.

[4]  Á. López-González,et al.  Waist Circumference Is an Essential Factor in Predicting Insulin Resistance and Early Detection of Metabolic Syndrome in Adults , 2023, Nutrients.

[5]  Xuelian Fu,et al.  Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease , 2022, Diabetology & metabolic syndrome.

[6]  Huan Liu,et al.  Comparison of different insulin resistance surrogates to predict hyperuricemia among U.S. non-diabetic adults , 2022, Frontiers in Endocrinology.

[7]  Wen-Cheng Li,et al.  Gender differences in the association between insulin resistance and chronic kidney disease in a Chinese population with metabolic syndrome , 2022, Diabetology & Metabolic Syndrome.

[8]  R. Hegele,et al.  Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk , 2022, Journal of the American Heart Association.

[9]  Safeera Khan,et al.  Bempedoic Acid’s Use as an Adjunct in Lowering Low-Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease: A Systematic Review , 2022, Cureus.

[10]  B. Zubelewicz-Szkodzińska,et al.  Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome , 2022, Nutrients.

[11]  Á. López-González,et al.  Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers , 2022, Journal of nutrition and metabolism.

[12]  Wei Li,et al.  Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease , 2022, Frontiers in Cardiovascular Medicine.

[13]  T. Igusa,et al.  The Baltimore Urban Food Distribution (BUD) App: Study Protocol to Assess the Feasibility of a Food Systems Intervention , 2022, International journal of environmental research and public health.

[14]  Hanmei Xu,et al.  Trends in insulin resistance: insights into mechanisms and therapeutic strategy , 2022, Signal Transduction and Targeted Therapy.

[15]  Xin Zhang,et al.  Correlation Between Non-insulin-Based Insulin Resistance Indices and Increased Arterial Stiffness Measured by the Cardio–Ankle Vascular Index in Non-hypertensive Chinese Subjects: A Cross-Sectional Study , 2022, Frontiers in Cardiovascular Medicine.

[16]  A. Alamoudi,et al.  Modulation of Dyslipidemia Markers Apo B/Apo A and Triglycerides/HDL-Cholesterol Ratios by Low-Carbohydrate High-Fat Diet in a Rat Model of Metabolic Syndrome , 2022, Nutrients.

[17]  Xin Zhang,et al.  Correlation between non‐insulin‐based insulin resistance indexes and the risk of prehypertension: A cross‐sectional study , 2022, Journal of clinical hypertension.

[18]  C. Busquets-Cortés,et al.  Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study , 2022, Nutrients.

[19]  R. Blankstein,et al.  Social determinants of health and obesity: Findings from a national study of US adults , 2022, Obesity.

[20]  J. Božić,et al.  Can Fasting Curb the Metabolic Syndrome Epidemic? , 2022, Nutrients.

[21]  Shin-ichiro Taira,et al.  Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients , 2022, Lipids in health and disease.

[22]  Yu-Jin Kwon,et al.  Comparison of the triglyceride glucose (TyG) index, triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, and metabolic score for insulin resistance (METS-IR) associated with periodontitis in Korean adults , 2022, Therapeutic advances in chronic disease.

[23]  H. Assi,et al.  Metabolic Syndrome: Updates on Pathophysiology and Management in 2021 , 2022, International journal of molecular sciences.

[24]  T. Yokoo,et al.  Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review , 2021, Nutrients.

[25]  Young Sik Kim,et al.  Relationships between fasting glucose levels, lifestyle factors, and metabolic parameters in Korean adults without diagnosis of diabetes mellitus , 2021, Journal of diabetes.

[26]  Z. Fan,et al.  Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in the general population: a systematic review and meta-analysis of cohort studies , 2021, Nutrition, Metabolism and Cardiovascular Diseases.

[27]  M. Laakso,et al.  The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease , 2021, Metabolites.

[28]  A. R. Srinivasan,et al.  Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. , 2021, Maedica.

[29]  A. Aguirre-Jaíme,et al.  [Effectiveness of the TG/HDL-C ratio to improve GLP-1 prescription in patients with type 2 diabetes in primary care]. , 2021, Semergen.

[30]  A. Astrup,et al.  Sexual Dimorphism in Body Weight Loss, Improvements in Cardiometabolic Risk Factors and Maintenance of Beneficial Effects 6 Months after a Low-Calorie Diet: Results from the Randomized Controlled DiOGenes Trial , 2021, Nutrients.

[31]  J. Heeren,et al.  Metabolic-associated fatty liver disease and lipoprotein metabolism , 2021, Molecular metabolism.

[32]  G. Norata,et al.  Global epidemiology of dyslipidaemias , 2021, Nature Reviews Cardiology.

[33]  G. Biasucci,et al.  Early Prevention of Atherosclerosis: Detection and Management of Hypercholesterolaemia in Children and Adolescents , 2021, Life.

[34]  P. Libby.  The changing landscape of atherosclerosis , 2021, Nature.

[35]  Sabuj Khadka,et al.  Heterogeneities in Consumer Diet Quality and Health Outcomes of Consumers by Store Choice and Income , 2021, Nutrients.

[36]  N. Moradi,et al.  Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women , 2020, Lipids in health and disease.

[37]  M. Banach,et al.  Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study , 2020, Metabolites.

[38]  V. Fuster,et al.  Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. , 2020, Journal of the American College of Cardiology.

[39]  X. Liu,et al.  Associations of Triglyceride-Glucose Index and Its Derivatives with Hyperuricemia Risk: A Cohort Study in Chinese General Population , 2020, International journal of endocrinology.

[40]  P. Pérez-Martínez,et al.  Dietary habits, lipoprotein metabolism and cardiovascular disease: From individual foods to dietary patterns , 2020, Critical reviews in food science and nutrition.

[41]  Engin Mesut,et al.  Is it possible to predict the complexity of peripheral artery disease with atherogenic index? , 2020, Vascular.

[42]  N. Cook,et al.  Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease. , 2020, Journal of the American College of Cardiology.

[43]  G. Russo,et al.  Atherogenic dyslipidemia and diabetic nephropathy , 2020, Journal of Nephrology.

[44]  Yan Chen,et al.  Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients , 2020, BMC Nephrology.

[45]  Haofei Hu,et al.  Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study , 2020, Lipids in Health and Disease.

[46]  Xiuhua Guo,et al.  Association between the triglyceride to high-density lipoprotein cholesterol ratio and the risk of type 2 diabetes mellitus among Chinese elderly: the Beijing Longitudinal Study of Aging , 2020, BMJ Open Diabetes Research & Care.

[47]  A. Lorenzatti,et al.  New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease , 2019, European cardiology.

[48]  Aijaz Ahmed,et al.  Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease , 2019, Journal of clinical and translational hepatology.

[49]  J. Ascaso,et al.  Control of the overall lipid profile. , 2019, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[50]  F. Lenfant,et al.  Sex differences in metabolic regulation and diabetes susceptibility , 2019, Diabetologia.

[51]  C. Damaskos,et al.  Assessing Cardiovascular Risk in Patients with Diabetes: An Update , 2019, Current cardiology reviews.

[52]  I. Tzeng,et al.  Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: a cross-sectional study , 2019, Lipids in Health and Disease.

[53]  A. Piwowar,et al.  Indirect insulin resistance detection: Current clinical trends and laboratory limitations. , 2019, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[54]  Hong-Kyu Kim,et al.  Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes , 2019, Scientific Reports.

[55]  Ryan Basith Fasih Khan,et al.  From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research , 2019, Medicina.

[56]  P. Libby,et al.  Atherosclerosis , 2019, Nature Reviews Disease Primers.

[57]  Johannes Scherr,et al.  Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors , 2019, European journal of preventive cardiology.

[58]  Shouling Wu,et al.  Higher triglyceride to high‐density lipoprotein cholesterol ratio increases cardiovascular risk: 10‐year prospective study in a cohort of Chinese adults , 2019, Journal of diabetes investigation.

[59]  J. Sowers,et al.  Utility of obesity and metabolic dyslipidemia (a non‐insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness , 2019, Journal of clinical hypertension.

[60]  A. Magdy,et al.  Evaluation Of TG-HDL Ratio Instead Of HOMA Ratio As Insulin Resistance Marker In Overweight And Children With Obesity. , 2019, Endocrine, metabolic & immune disorders drug targets.

[61]  Neelay Mehendale,et al.  Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation , 2019, Free radical research.

[62]  E. Janda,et al.  Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols , 2019, Nutrients.

[63]  A. Stefanović,et al.  Obesity and dyslipidemia. , 2019, Metabolism: clinical and experimental.

[64]  K. Taylor,et al.  The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans. , 2019, Journal of diabetes and its complications.

[65]  N. Sarrafzadegan,et al.  Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria , 2016, Journal of research in health sciences.

[66]  V. Benites-Zapata,et al.  High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults. , 2019, Diabetes & metabolic syndrome.

[67]  T. Hirano.  Pathophysiology of Diabetic Dyslipidemia , 2018, Journal of atherosclerosis and thrombosis.

[68]  Claudio Aguayo,et al.  Association between insulin resistance and the development of cardiovascular disease , 2018, Cardiovascular Diabetology.

[69]  D. Zozulinska-Ziolkiewicz,et al.  TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice. , 2018, Journal of clinical lipidology.

[70]  Omar Yaxmehen Bello-Chavolla,et al.  METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. , 2018, European journal of endocrinology.

[71]  P. Newsholme,et al.  Molecular mechanisms of ROS production and oxidative stress in diabetes. , 2016, The Biochemical journal.

[72]  S. Taleb.  Inflammation in atherosclerosis. , 2016, Archives of cardiovascular diseases.

[73]  M. Brownlee,et al.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. , 2016, Circulation research.

[74]  M. Ruscica,et al.  Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia , 2016, Endocrine.

[75]  C. Aguilar-Salinas,et al.  Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[76]  S. Benozzi,et al.  Triglycerides and glucose index: a useful indicator of insulin resistance. , 2014, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[77]  P. Toth.  Insulin resistance, small LDL particles, and risk for atherosclerotic disease. , 2014, Current vascular pharmacology.

[78]  J. M. Carrasco,et al.  [Proposals for social class classification based on the Spanish National Classification of Occupations 2011 using neo-Weberian and neo-Marxist approaches]. , 2013, Gaceta sanitaria.

[79]  Kyung-Hyun Cho,et al.  Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. , 2009, BMB reports.

[80]  S. Grundy.  Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. , 2006, Clinical cornerstone.

[81]  M. Rizzo,et al.  Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? , 2005, Journal of atherosclerosis and thrombosis.

[82]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.